Ryan N. Henderson

Array ( [id] => 5848692 [patent_doc_number] => 20020133842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Transgenic mice containing deubiquitinated enzyme gene disruptions' [patent_app_type] => new [patent_app_number] => 10/012740 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20846 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133842.pdf [firstpage_image] =>[orig_patent_app_number] => 10012740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6115871 [patent_doc_number] => 20020174450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Transgenic mice containing cash gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005921 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20561 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0174/20020174450.pdf [firstpage_image] =>[orig_patent_app_number] => 10005921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5848690 [patent_doc_number] => 20020133840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Transgenic mice containing disruptions in genes encoding A2D2 calcium ion channel subunit proteins' [patent_app_type] => new [patent_app_number] => 10/005168 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20443 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133840.pdf [firstpage_image] =>[orig_patent_app_number] => 10005168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5927037 [patent_doc_number] => 20020116728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005202 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20723 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20020116728.pdf [firstpage_image] =>[orig_patent_app_number] => 10005202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5848685 [patent_doc_number] => 20020133839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Transgenic mice containing Kir2.3 potassium channel gene disruptions' [patent_app_type] => new [patent_app_number] => 09/999254 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20293 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133839.pdf [firstpage_image] =>[orig_patent_app_number] => 09999254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6676026 [patent_doc_number] => 20030061629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Production of transgenic birds using stage X primordial germ cells' [patent_app_type] => new [patent_app_number] => 09/992634 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17395 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20030061629.pdf [firstpage_image] =>[orig_patent_app_number] => 09992634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5848709 [patent_doc_number] => 20020133844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Regulation of Th2 cell activity by modulation of NFATp and NFAT4 activity' [patent_app_type] => new [patent_app_number] => 10/035688 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20358 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133844.pdf [firstpage_image] =>[orig_patent_app_number] => 10035688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5830888 [patent_doc_number] => 20060064766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'HISTAMINE RECEPTOR H3 MODIFIED TRANSGENIC MICE' [patent_app_type] => utility [patent_app_number] => 09/993159 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5642 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20060064766.pdf [firstpage_image] =>[orig_patent_app_number] => 09993159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791559 [patent_doc_number] => 20030086903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Therapeutic regimen for treating cancer' [patent_app_type] => new [patent_app_number] => 10/001017 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16808 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086903.pdf [firstpage_image] =>[orig_patent_app_number] => 10001017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1089678 [patent_doc_number] => 06828433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'DNA encoding mutated collagen X' [patent_app_type] => B2 [patent_app_number] => 09/975607 [patent_app_country] => US [patent_app_date] => 2001-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 36 [patent_no_of_words] => 11457 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828433.pdf [firstpage_image] =>[orig_patent_app_number] => 09975607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838474 [patent_doc_number] => 20030035814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Recombinant influenza viruses for vaccines and gene therapy' [patent_app_type] => new [patent_app_number] => 09/971372 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13933 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035814.pdf [firstpage_image] =>[orig_patent_app_number] => 09971372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408212 [patent_doc_number] => 20020037870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Method of inhibiting cancer cell growth using a vector expressing pRb2/p130' [patent_app_type] => new [patent_app_number] => 09/969988 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12116 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037870.pdf [firstpage_image] =>[orig_patent_app_number] => 09969988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779184 [patent_doc_number] => 20030050266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Anti-tumor effects of prostate carcinoma tumor antigen-1' [patent_app_type] => new [patent_app_number] => 09/948227 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14700 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050266.pdf [firstpage_image] =>[orig_patent_app_number] => 09948227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6140854 [patent_doc_number] => 20020001581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Methods for transducing cells in blood vessels using recombinant AAV vectors' [patent_app_type] => new [patent_app_number] => 09/938200 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12996 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20020001581.pdf [firstpage_image] =>[orig_patent_app_number] => 09938200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865227 [patent_doc_number] => 20030190753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Vectors for gene transfer' [patent_app_type] => new [patent_app_number] => 09/934113 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23399 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190753.pdf [firstpage_image] =>[orig_patent_app_number] => 09934113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884241 [patent_doc_number] => 07351580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed' [patent_app_type] => utility [patent_app_number] => 10/343339 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8192 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351580.pdf [firstpage_image] =>[orig_patent_app_number] => 10343339 [rel_patent_id] =>[rel_patent_doc_number] =>)